Squamous syringometaplasia associated with docetaxel.
Karam
A
A
Metges
J P
JP
Labat
J P
JP
Leroy
J P
JP
Guillet
G
G
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D000077143:Docetaxel; D004938:Esophageal Neoplasms / Q000188:drug therapy; D006801:Humans; D008297:Male; D008679:Metaplasia / Q000139:chemically induced; D008875:Middle Aged; D009336:Necrosis; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives*; D013544:Sweat Gland Neoplasms / Q000139:chemically induced* / Q000473:pathology; D013545:Sweat Glands / Q000473:pathology; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel